Zhihong Liu

This study identifies HIF2-driven PTHrP as a cause of cachexia and hypercalcemia in kidney cancer and shows that HIF2 inhibitors can alleviate these symptoms.

This paper introduces PepGenWOA, a generative model for bioactive peptide design that outperforms existing methods and enables efficient virtual screening.